[go: up one dir, main page]

PL3240772T3 - Związki z antrodia camphorata, sposoby ich otrzymywania i ich zastosowanie - Google Patents

Związki z antrodia camphorata, sposoby ich otrzymywania i ich zastosowanie

Info

Publication number
PL3240772T3
PL3240772T3 PL15875258T PL15875258T PL3240772T3 PL 3240772 T3 PL3240772 T3 PL 3240772T3 PL 15875258 T PL15875258 T PL 15875258T PL 15875258 T PL15875258 T PL 15875258T PL 3240772 T3 PL3240772 T3 PL 3240772T3
Authority
PL
Poland
Prior art keywords
preparing
compounds
same
antrodia camphorata
camphorata
Prior art date
Application number
PL15875258T
Other languages
English (en)
Inventor
Chiung-Lin LIU
Wei-Tse Tsai
Kai-Hsin HSIEH
Original Assignee
ONENESS BIOTECH CO., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ONENESS BIOTECH CO., Ltd filed Critical ONENESS BIOTECH CO., Ltd
Publication of PL3240772T3 publication Critical patent/PL3240772T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12Acetic acid esters
    • C07C69/21Acetic acid esters of hydroxy compounds with more than three hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • C07C45/79Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/577Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • C07C67/56Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL15875258T 2014-12-30 2015-12-30 Związki z antrodia camphorata, sposoby ich otrzymywania i ich zastosowanie PL3240772T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462098177P 2014-12-30 2014-12-30
EP15875258.4A EP3240772B1 (en) 2014-12-30 2015-12-30 Compounds from antrodia camphorata, method for preparing the same and use thereof
PCT/CN2015/099894 WO2016107582A1 (en) 2014-12-30 2015-12-30 Compounds from antrodia camphorata, method for preparing the same and use thereof

Publications (1)

Publication Number Publication Date
PL3240772T3 true PL3240772T3 (pl) 2021-06-28

Family

ID=56163420

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15875258T PL3240772T3 (pl) 2014-12-30 2015-12-30 Związki z antrodia camphorata, sposoby ich otrzymywania i ich zastosowanie

Country Status (9)

Country Link
US (1) US9884801B2 (pl)
EP (1) EP3240772B1 (pl)
JP (1) JP6896630B2 (pl)
CN (1) CN105732381B (pl)
ES (1) ES2869904T3 (pl)
MY (1) MY173104A (pl)
PL (1) PL3240772T3 (pl)
TW (1) TWI648257B (pl)
WO (1) WO2016107582A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106063800B (zh) * 2016-08-01 2020-02-18 上海交通大学 牛樟芝在抗前列腺增生药物中的应用
WO2018094122A1 (en) 2016-11-18 2018-05-24 Golden Biotechnology Corporation Methods and compositions for treating atopic dermatitis
CN108409571A (zh) * 2018-03-23 2018-08-17 中国药科大学 从金刚纂中提取的用于治疗癌症的化合物
JP2022523521A (ja) * 2019-02-25 2022-04-25 アージル・バイオテック・ホールディング・カンパニー・リミテッド ウイルス感染を阻害するための方法および組成物
CN113831221B (zh) * 2021-09-18 2023-04-07 云南民族大学 一种倍半萜类化合物及其制备方法与应用
CN114487252B (zh) * 2021-12-28 2024-03-26 陕西嘉禾生物科技股份有限公司 一种用于区别牛樟芝和牛樟木的薄层色谱鉴别方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6247838B1 (en) 1998-11-24 2001-06-19 The Boc Group, Inc. Method for producing a liquid mixture having a predetermined concentration of a specified component
US7531627B2 (en) 2003-12-19 2009-05-12 Po-Jung Chien Protein ACA1 of Antrodia camphorata
US7109232B2 (en) 2004-03-08 2006-09-19 Simpson Biotech Co., Ltd. Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity
ATE513823T1 (de) 2004-08-17 2011-07-15 Simpson Biotech Co Ltd Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung
US7601854B2 (en) 2006-10-25 2009-10-13 Kang Jian Biotech Corp., Ltd. Diterpenes from the fruiting body of Antrodia camphorata and pharmaceutical compositions thereof
TW200829234A (en) 2007-01-08 2008-07-16 Golden Biotechnology Corp Antrodia camphorata isophorone extract
TW200918498A (en) 2007-10-19 2009-05-01 Golden Biotechnology Corp Novel compound isolated from Antrodia camphorate extracts
CN101417934B (zh) * 2007-10-24 2012-04-18 国鼎生物科技股份有限公司 分离自牛樟芝萃取物的化合物
TW201000112A (en) 2008-06-18 2010-01-01 Mackay Memorial Hospital Use of dehydrosulphurenic acid for inhibiting the growth of cancer cells
US8309611B2 (en) * 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer
CN103796647A (zh) * 2011-06-10 2014-05-14 国鼎生物科技股份有限公司 用于治疗脑癌的方法和组合物
CN103570531A (zh) * 2012-07-25 2014-02-12 丽丰实业股份有限公司 樟芝菌丝体的化合物及其用途
JP5908002B2 (ja) * 2013-03-20 2016-04-26 卉菱 曽 ベニクスノキタケに含まれる化合物及びその用途
TWI583376B (zh) * 2013-03-20 2017-05-21 Hui-Ling Zeng Compounds isolated from Antelroxicus and their use
CN104177240B (zh) * 2013-05-28 2016-10-19 曾卉菱 分离自牛樟芝的化合物、萃取物及其用途
CN104211627A (zh) * 2013-05-29 2014-12-17 曾卉菱 牛樟芝化合物、萃取物及其用途
US9249117B2 (en) * 2014-05-20 2016-02-02 Hui Ling Tseng Use of compounds from Antrodia camphorata in manufacturing medicaments for treating kidney diseases

Also Published As

Publication number Publication date
EP3240772B1 (en) 2021-03-03
JP6896630B2 (ja) 2021-06-30
JP2018507175A (ja) 2018-03-15
CN105732381A (zh) 2016-07-06
US20160185703A1 (en) 2016-06-30
TWI648257B (zh) 2019-01-21
EP3240772A1 (en) 2017-11-08
CN105732381B (zh) 2021-07-20
ES2869904T3 (es) 2021-10-26
WO2016107582A1 (en) 2016-07-07
TW201623208A (zh) 2016-07-01
US9884801B2 (en) 2018-02-06
EP3240772A4 (en) 2018-08-29
MY173104A (en) 2019-12-26

Similar Documents

Publication Publication Date Title
SG11201607030PA (en) Antibodies, uses & methods
HUE052730T2 (hu) Eljárás klór elõállításához használt katalizátor elõállítására, katalizátor és eljárás klór elõállítására
HK1232210A1 (zh) 製備 -四氯丙烯的方法
SG11201704160XA (en) Antibodies, uses & methods
PL3240772T3 (pl) Związki z antrodia camphorata, sposoby ich otrzymywania i ich zastosowanie
EP3216521A4 (en) Carrier-nanoparticle complex, method for preparing same, and catalyst comprising same
EP3112351A4 (en) Naphthylamide compound, preparation method and use thereof
SG11201703631VA (en) Novel carbodiimides, method for the production and use thereof
HUE036789T2 (hu) Szintéziseljárás 1,2-benzizotiazolin-3-on elõállítására
EP3177744A4 (en) Material, method&component
EP3157016A4 (en) Scintillator, preparing method thereof, and application thereof
PL3178803T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
GB201421408D0 (en) An agrochemical composition, a method of preparing the same and the use thereof
EP3235564A4 (en) Method for preparing catalyst
IL250223A0 (en) A method for the preparation of the pyrimidin-1-ol compound, and its intermediates
EP3201164A4 (en) Processes for preparing 2,5-dichlorophenol
EP3192792A4 (en) Aminosulfonyl compound, preparation method therefor and use thereof
IL249620A0 (en) Method for preparing 4-Alkoxy-1,1,1-trifluororobot-3-en-2-ones from 1,1,1-trifluoroacetone
SG11201704201VA (en) Catalyst and preparation method thereof, and method for preparing isobutylene by applying the same
SG11201700276QA (en) Quinoxaline compounds, method for preparing the same and use thereof
EP3162437A4 (en) Catalyst for synthesizing theaflavin and method for synthesizing theaflavin
IL251229A0 (en) Process for preparing 5-bromo-1,2,3-trichlorobenzene
GB2530420B (en) Connecting apparatus, assembly & method
GB201413950D0 (en) Antibodies, uses & methods
GB201400597D0 (en) Antibodies, uses & methods